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background: It was reported that tissue morphology of in-stent restenosis (ISR) lesions after drug-eluting stent (DES) implantation assessed with 
optical coherence tomography (OCT) was affected by stent type. Little was known about the re-restenotic tissue morphology after paclitaxel-coated 
balloon (PCB) dilatation and plain old balloon angioplasty (POBA). The aim of this study was to examine tissue morphology of in-stent re-restenosis 
lesions after PCB dilatation and POBA for DES-ISR lesions and to clarify the impact of previous stent type on it.
Methods: Between January 2009 and March 2013, we performed OCT for in-stent re-restenosis lesions after PCB dilatation in 46 patients and 
those after POBA in 41 patients. Previous stents were 63 first generation DESs (sirolimus-eluting stent and paclitaxel-eluting stent) and 24 second 
generation DESs (zotarolimus-eluting stent, everolimus-eluting stent, and biolimus-eluting stent). The morphological assessment of neointimal tissue 
structure (homogeneous, heterogeneous, and layered type) was performed.
results: The results were shown in figure. There is a significant difference in tissue structure of in-stent re-restenosis lesions after PCB or POBA 
between 1st and 2nd generation DES (p=0.037). However, there was no difference in tissue structure between PCB dilatation and POBA in both 1st 
and 2nd generation DES.
conclusions: The tissue morphology of in-stent re-restenosis might be affected not by treatment modality but by previous stent type.
